Search Results
Found 5 results
510(k) Data Aggregation
(78 days)
Section: | 882.4545
THE MINOP® DISPOSABLE INTRODUCER IS INDICATED TO OBTAIN AND MAINTAIN A TEMPORARY PATHWAY INTO THE VENTRICULAR SYSTEM OF THE BRAIN.
The MINOP® Disposable Introducer is a single used to obtain ventricular access and facilitate endoscope insertion. The MINOP® Disposable Introducer consists of an introducer sheath and a ventricular obturator.
The document provided is a 510(k) premarket notification for the MINOP® Disposable Introducer. This type of submission relies on demonstrating substantial equivalence to a predicate device rather than comprehensive clinical studies with detailed acceptance criteria and standalone performance metrics typically associated with AI/ML device evaluations.
Therefore, many of the requested categories related to AI/ML device studies (such as MRMC studies, training set details, expert qualifications for ground truth, etc.) are not applicable to this submission.
Here's a breakdown of the available information based on your request:
1. Table of Acceptance Criteria and Reported Device Performance
The document does not explicitly state formal acceptance criteria in a quantitative table for multiple performance metrics. Instead, it refers to equivalence to a predicate device and internal standards for peel force.
| Feature/Test | Acceptance Criteria (or Comparison) | Reported Device Performance |
|---|---|---|
| Peel Force | Meets requirements defined in Medcomp's internal standards for force at break (of the sheath). | "Results of the peel force testing meet the requirements defined in Medcomp's internal standards for force at break." (The document states the MINOP® Disposable Introducer's sheath design (with ink depth markings) and obturator tip rounding do not affect the peel force relative to the predicate.) |
| Material | Substantially equivalent to Medcomp Vascu-Sheath® Introducer Set. | The document states "sheath are identical to the legally marketed Medcomp device." |
| Design | Substantially equivalent to Medcomp Vascu-Sheath® Introducer Set. | Minor differences: obturator has a rounded tip, sheath has ink depth markings. These were deemed not to affect peel force. |
| Sterilization | Substantially equivalent to Medcomp Vascu-Sheath® Introducer Set. | Not explicitly detailed, but implied by the claim of substantial equivalence. |
| Indications for Use | Equivalent to Medtronic PS Medical Endoscope Introducer. | "The MINOP® Disposable Introducer is indicated to obtain and maintain a temporary pathway into the ventricular system of the brain." |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: Not specified in the document. The performance data section vaguely refers to "Performance testing" and "Results of the peel force testing" without giving specific numbers of units tested.
- Data Provenance: The testing was "in-vitro" and relates to the physical properties of the device components. There is no information regarding country of origin or whether it was retrospective or prospective, as it's not a clinical study involving patient data.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications
Not Applicable. This is an invivo mechanical/material performance test, not a study requiring expert readers to establish ground truth. The "ground truth" here is the physical measurement of peel force against defined internal standards.
4. Adjudication Method for the Test Set
Not Applicable. There's no "adjudication" in the sense of reconciling divergent expert opinions, as this is a physical performance test.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done
No. An MRMC study was not done. The submission relies on substantial equivalence to predicate devices, supported by in-vitro mechanical testing.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Study Was Done
Not Applicable. This is a physical medical device, not an AI/ML algorithm.
7. The Type of Ground Truth Used
The ground truth used for the peel force analysis was "Medcomp's internal standards for force at break." This refers to a predefined, objective standard for mechanical performance.
8. The Sample Size for the Training Set
Not Applicable. This device did not involve machine learning; therefore, there was no training set.
9. How the Ground Truth for the Training Set Was Established
Not Applicable. As there was no training set, this question is not relevant.
Ask a specific question about this device
(84 days)
of safety and effectiveness is submitted in accordance with the requirements of SMDA 1990 and 21 CFR 882.4545
|
| Common usual or Classification Name: | Instrument, Shunt System(882.4545
The Introducer Sheath is a device used to make a channel through the brain into the ventricular system.
The Introducer Sheath includes two parts, a peelaway sheath and a blunt ended obturator, which fits inside the sheath. The Introducer Sheath provides an atraumatic passage into the ventricular system.
The provided document is a 510(k) premarket notification for a medical device called the "Medtronic PS Medical Endoscope Introducer." This type of document focuses on demonstrating substantial equivalence to a previously legally marketed device, rather than providing detailed acceptance criteria and a specific study proving the device meets those criteria.
Therefore, many of the requested details about performance, sample sizes, ground truth establishment, and comparative effectiveness studies are not available in this document. The document's purpose is to show that the new device is as safe and effective as existing ones, based on similar design and intended use.
Here's an analysis based on the information available in the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
The document does not provide a table of acceptance criteria or specific performance metrics that the Medtronic PS Medical Endoscope Introducer was tested against in a formal study.
Instead, the document asserts technological comparison and substantial equivalence to predicate devices (Navigational F Sheath and Codman Peel Away Sheath) based on:
- Device configuration/contents: Peel Away Sheath, Obturator
- Sterility Method: EtO (Ethylene Oxide)
- Sterile: Sterile single-use device
- Intended Use: To make a channel through the brain into the ventricular system.
The "reported device performance" is implicitly that it performs like the predicate devices, enabling the creation of a channel through the brain for ventricular access. No quantitative performance data is provided.
2. Sample Size Used for the Test Set and Data Provenance
This information is not provided in the document. As a 510(k) submission based on substantial equivalence, it relies on the established safety and effectiveness of the predicate devices. There is no mention of a specific test set or data derived from testing the Medtronic PS Medical Endoscope Introducer.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications
This information is not provided. Ground truth establishment for a test set is typically part of a dedicated performance study, which is not detailed in this 510(k) submission.
4. Adjudication Method for the Test Set
This information is not provided.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done
No, an MRMC comparative effectiveness study was not done (or at least, not reported in this document). The 510(k) process for this device relies on demonstrating equivalence to predicate devices, not on a human-in-the-loop study with AI.
6. If a Standalone (Algorithm Only Without Human-in-the-Loop Performance) was Done
This device is a physical medical instrument, not an algorithm or AI. Therefore, the concept of "standalone (algorithm only)" performance is not applicable to this product.
7. The Type of Ground Truth Used
The "ground truth" here is not clinical outcome data or expert consensus on performance of the new device. Instead, the "ground truth" for this 510(k) submission is implicitly the established safety and effectiveness of the predicate devices (Navigational F Sheath (K931973) and Codman Peel Away Sheath (K883607)), which allow for the "creation of a channel through the brain into the ventricular system." The new device is deemed substantially equivalent in its design, materials, and intended use.
8. The Sample Size for the Training Set
This information is not applicable and not provided. This is a physical device, not an AI or machine learning model that requires a training set.
9. How the Ground Truth for the Training Set Was Established
This information is not applicable and not provided.
Ask a specific question about this device
(76 days)
Classification name:
Accessories to shunt system implantaton instruments, regulation number 21 CFR 882.4545
The Delia Localizer and Caroline Guide are indicated for use by neurosurgeons as shunt accessories for patients scheduled to undergo a posterior ventricular catheter placement procedure who are: 1) Adults 2) Have enlarged ventricles 3) Have normal scalp, skull, external ear and orbital anatomy 4) Do not have intracranial mass lesions or any structural abnormalities other than hydrocephalus 5) Have no general contraindications to surgery
The Delia Localizer is a head-band based apparatus that aids the surgeon in identifying the optimal location for placing a posterior burr hole for purposes of inserting a posterior ventricular catheter. It mechanically reduces to practice geometric principles that are already used to manually calculate where to position a posterior burr hole. The Caroline Guide is a mechanical device that helps the surgeon orient a ventricular catheter along a straight line connecting the posterior burr hole entrance point and the frontal target point.
The provided text describes a 510(k) summary for the "Caroline Guide and Delia Localizer" integrated system. However, it does not explicitly state specific numerical acceptance criteria or detail a study designed to prove the device meets these criteria in the typical quantitative manner we might expect for medical device performance evaluation.
Instead, the document focuses on:
- Substantial Equivalence: The primary goal of the 510(k) submission is to demonstrate that the new device is "substantially equivalent" to a legally marketed predicate device (a ventricular catheter stylette).
- Technological Characteristics: It highlights similarities in indications for use, method for advancing the catheter, and patient exposure to materials, while describing how the new device mechanically simplifies existing manual techniques.
- Pre-clinical Testing: This testing focused on confirming geometric principles and mechanical accuracy.
- Clinical Testing: A clinical trial of the Caroline Guide alone was reported in peer-reviewed literature. More recently, a clinical trial of the combined Delia Localizer and Caroline Guide system was approved, and clinical data on its performance was "now available."
Given this, I will reconstruct the "acceptance criteria" and "study" information based on the emphasis of the 510(k) process, which prioritizes safety and effectiveness demonstrated through substantial equivalence rather than explicit quantitative performance metrics like sensitivity/specificity often seen in AI/diagnostic device submissions.
Here's a breakdown of the requested information based on the provided text:
Acceptance Criteria and Device Performance
The concept of "acceptance criteria" in this 510(k) notice is primarily framed around the demonstration of substantial equivalence to a predicate device, and ensuring the new technological features do not adversely affect safety or effectiveness. Specific quantitative performance metrics are not provided as acceptance criteria.
| Acceptance Criteria (Implied by 510(k) content) | Reported Device Performance (Summary from text) |
|---|---|
| 1. Substantial Equivalence to Predicate Device: Same indications for use, method for advancing catheter, and materials exposure. | Met: The integrated system shares the same indications for use, method for advancing the catheter into the ventricle, and materials exposure to the patient during surgery as the predicate ventricular catheter stylette. The new features mechanically simplify existing manual techniques. |
| 2. Validity of Geometric Principles (Delia Localizer): Accurate embodiment of established geometric principles for burr hole placement. | Met: Pre-clinical testing involved anatomical analysis of CT scans of hydrocephalus patients, confirming the validity of the geometric principles. Testing on cranial phantoms of differing head sizes ensured accurate reduction of principles to practice. |
| 3. Mechanical Accuracy (Caroline Guide): Maintenance of catheter alignment with the frontal target point. | Met: Non-clinical studies confirmed that ventricular catheters passed through the guide tube maintained alignment with the frontal target point as advanced by hand. |
| 4. Safety and Effectiveness (Combined System): New technological features do not adversely affect safety or effectiveness. | Met: Pre-clinical and clinical test data indicate that the new technologic features of the Delia Localizer and Caroline Guide "do not adversely affect safety or effectiveness in a way that is consequential under the conditions of intended use." Clinical data from a trial using the combined system was available (approved by the University of Iowa Institutional Review Board). |
Study Details
The text describes both non-clinical and clinical tests. The primary "study" proving the device meets the substantial equivalence criteria encompasses these findings.
2. Sample size used for the test set and the data provenance:
- Delia Localizer (Pre-clinical):
- Test Set: Head CT scans of patients with hydrocephalus (number not specified).
- Provenance: Not explicitly stated, but implies clinical data from patients with hydrocephalus. The cranial phantoms used were for "differing head sizes."
- Caroline Guide (Non-clinical):
- Test Set: Not a human sample size, but involved testing with ventricular catheters and the guide tube.
- Caroline Guide (Clinical - standalone):
- Test Set: Not explicitly stated, but a clinical trial was conducted at the Universities of Iowa and Washington. This trial was reported in peer-reviewed literature in 1995. This would be prospective data given it was a trial.
- Delia Localizer + Caroline Guide (Clinical - combined system):
- Test Set: Clinical data (number of patients not specified) from a new clinical trial approved by the University of Iowa Institutional Review Board. This would be prospective data.
- Provenance: University of Iowa.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- For the pre-clinical analysis of CT scans, "anatomical analysis" was performed, which implies expert involvement, but the number and qualifications of experts are not specified.
- For the clinical trials, it is implied that neurosurgeons were involved in using and evaluating the device, but their number and specific qualifications for establishing 'ground truth' or evaluating outcomes are not detailed in this summary.
4. Adjudication method for the test set:
- Not specified. The 510(k) summary does not provide details on adjudication methods for either the pre-clinical or clinical studies.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, if so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- No, an MRMC study was not done. This device is a mechanical surgical guide, not an AI-assisted diagnostic tool. Therefore, the concept of "human readers improve with AI vs without AI assistance" does not apply. The comparison is between manual surgical techniques and mechanically guided techniques. The summary states that the new device "mechanically reduces to practice geometric principles that are already used to manually calculate."
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
- Yes, in essence. The pre-clinical tests for the Delia Localizer (validity of geometric principles, accuracy on phantoms) and the non-clinical tests for the Caroline Guide (mechanical accuracy with catheters) can be considered "standalone" evaluations of the device's mechanical function, prior to or separate from human-in-the-loop clinical use.
7. The type of ground truth used:
- Delia Localizer (Pre-clinical): Established geometric principles related to burr hole placement, confirmed by "anatomical analysis of head CT scans" and testing against physical cranial phantoms.
- Caroline Guide (Non-clinical): Mechanical alignment with a "frontal target point."
- Clinical Trials (Caroline Guide alone and combined system): Clinical performance, which for a surgical guidance device typically involves outcomes like successful catheter placement, reduction in complications, accuracy of placement, and patient safety. The specific metrics are not detailed but would be expert-assessed clinical outcomes.
8. The sample size for the training set:
- Not applicable in the typical sense of machine learning. This device is mechanical, not an AI/ML algorithm that requires a "training set." The development of the device would have been基于engineering principles and anatomical knowledge rather than data training.
9. How the ground truth for the training set was established:
- Not applicable as there is no "training set" in the context of an AI/ML algorithm. The "ground truth" for the device's design principles was established through anatomical and geometric understanding, surgical practice, and pre-clinical verification.
Ask a specific question about this device
(402 days)
Neurosurgical shunt system instruments are Class I (21 CFR 882.4545).
The Cordis Cyst Puncture Catheter Kit is intended to facilitate puncturing thick-walled or mobile intracranial cysts, allowing insertion of a ventricular catheter for cyst drainage.
The Cordis Cyst Puncture Catheter kit consists of a ventricular catheter with enlarged holes whose distal tip has been modification allows the sharpended stylet to be inserted through and locked into the distal tip. This facilitates cyst puncture. The kit also includes sharp- and blunt-ended stylets to facilitate catheter placement. The catheter is manufactured from silicone elastomer made radiopaque with barium sulfate.
This is a 510(k) premarket notification for a medical device (Cordis Cyst Puncture Catheter Kit) submitted in 1996. The provided text is a summary of safety and effectiveness, which primarily focuses on demonstrating substantial equivalence to predicate devices rather than proving the device meets specific performance acceptance criteria through a dedicated study.
In the context of 510(k) submissions from this era, a "study that proves the device meets the acceptance criteria" as you've described for AI/software devices is not typically conducted or summarized in this manner. Instead, the focus is on showing similarity in design, materials, manufacturing, and intended use to legally marketed predicate devices, and that these similarities do not raise new questions of safety or effectiveness.
Therefore, many of the specific questions you asked are not directly applicable or answerable from the provided text for this type of medical device submission. However, I can extract information related to what is present and explain why other information is absent.
Here's a breakdown of what can be inferred or stated based on the provided document:
Acceptance Criteria and Reported Device Performance
The document does not specify formal, quantitative "acceptance criteria" for performance in the way a modern AI/software device would. The core "acceptance" is that the device is substantially equivalent to predicate devices. This means that its design, materials, manufacturing methods, and intended use are similar enough not to raise new questions of safety or effectiveness.
| Acceptance Criteria (Implied) | Reported Device Performance |
|---|---|
| Functional Equivalence: The device can facilitate puncturing thick-walled or mobile intracranial cysts, allowing insertion of a ventricular catheter for cyst drainage. | The kit "is used to puncture and drain thick-walled or mobile intracranial cysts." The modified distal tip of the ventricular catheter with a sharp-ended stylet inserted facilitates cyst puncture, and the catheter can then be advanced for drainage. |
| Material/Design Compatibility: Materials and design are similar to predicate devices and do not raise new safety/effectiveness issues. | "The design, materials, manufacturing methods and specifications of the components of the Cordis Cyst Puncture Catheter Kit are similar to those of the predicate devices and do not raise any new issues relating to safety and effectiveness for their intended use." Silicone elastomer made radiopaque with barium sulfate is used, which is common. |
| Biocompatibility: The materials used are biocompatible. | "Section 5 for Biocompatibility Assessment" is referenced (though not provided in the excerpt), suggesting a separate assessment was made. This is a standard requirement for implantable devices. |
| Radiopacity: The catheter is radiopaque. | Made radiopaque with barium sulfate. "Appendix III for Radiopacity Validation Data" is referenced (though not provided in the excerpt), indicating validation was performed. |
Unanswerable or Not Applicable Questions (Based on the Provided Text)
The following questions cannot be answered from the provided text because they pertain to clinical or performance studies typically conducted for devices requiring more extensive proof of safety and effectiveness (e.g., PMA devices, or modern AI/software devices) or for which specific data is not detailed in a Summary of Safety and Effectiveness for a 510(k).
2. Sample size used for the test set and the data provenance: Not applicable. No "test set" in the context of controlled clinical trials or AI evaluation is described. The submission relies on substantial equivalence to predicate devices, which generally means no new clinical data demonstrating performance in a "test set" is required for the 510(k) pathway.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable. No ground truth establishment for a test set is described.
4. Adjudication method for the test set: Not applicable. No test set adjudication is described.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This is a medical device (catheter kit), not an AI/software device. No MRMC study was conducted.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done: Not applicable. This is a hardware medical device, not an AI algorithm.
7. The type of ground truth used: Not applicable in the conventional sense of clinical trials. The "ground truth" for a 510(k) is that the predicate devices are safe and effective, and the new device is sufficiently similar.
8. The sample size for the training set: Not applicable. This is a hardware medical device, not a machine learning model.
9. How the ground truth for the training set was established: Not applicable. This is a hardware medical device.
In summary: The provided document is a 510(k) summary focusing on demonstrating substantial equivalence to predicate devices. It relies on comparisons of design, materials, and intended use, rather than presenting clinical study data with defined acceptance criteria and performance metrics typical of more rigorous clinical trials for novel devices or AI/software. The "proof" of meeting "acceptance criteria" (which are implicit substantial equivalence) is the argument that the device is "similar to predicate devices and does not raise any new issues relating to safety and effectiveness for their intended use."
Ask a specific question about this device
(87 days)
|
| Proposed Classification: | Shunt System Implantation Instrument21 CFR 882.4545
The Reigel Tunneling Device is used for tunneling and passing shunt components under the skin for the placement of cerebrospinal fluid shunts from the head to the abdomen.
The Reigel Tunneling Device is used for tunneling and passing shunt components under the skin for the placement of cerebrospinal fluid shunts from the head to the abdomen. The device is supplied sterile. The materials comprising the device have an established history of use in medical product manufacturing.
This 510(k) Premarket Notification for the Reigel Tunneling Device does not contain any information about acceptance criteria or a study proving the device meets them.
The provided document is a 510(k) summary, which focuses on demonstrating substantial equivalence to a predicate device based on intended use, materials, and technological characteristics. It is not a clinical study report or a performance evaluation.
Therefore, I cannot provide the requested information, as it is not present in the input text.
Ask a specific question about this device
Page 1 of 1